Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2006-12-19

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.0609401103PMID 17164330PMCID PMC1698442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step.

  2006cited by this paper
• Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X.

  2005cited by this paper
• Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1

  2005cited by this paper
• Multiple myeloma: all roads lead to cyclin D

  2005cited by this paper
• Engineering of a Recombinant Vitamin K-dependent γ-Carboxylation System with Enhanced γ-Carboxyglutamic Acid Forming Capacity

  2005cited by this paper
• Increased Production of Functional Recombinant Human Clotting Factor IX by Baby Hamster Kidney Cells Engineered to Overexpress VKORC1, the Vitamin K 2,3-Epoxide-reducing Enzyme of the Vitamin K Cycle*

  2005cited by this paper
• Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system.

  2005cited by this paper
• Membrane Topology Mapping of Vitamin K Epoxide Reductase by in Vitro Translation/Cotranslocation*

  2005cited by this paper
• Vitamin K epoxide reductase: homology, active site and catalytic mechanism.

  2004cited by this paper
• Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

  2004cited by this paper
• Identification of the gene for vitamin K epoxide reductase

  2004cited by this paper
• Compound heterozygous mutations in the γ‐glutamyl carboxylase gene cause combined deficiency of all vitamin K‐dependent blood coagulation factors

  2004cited by this paper
• Binding of the Factor IX γ-Carboxyglutamic Acid Domain to the Vitamin K-dependent γ-Glutamyl Carboxylase Active Site Induces an Allosteric Effect That May Ensure Processive Carboxylation and Regulate the Release of Carboxylated Product*

  2004cited by this paper
• The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.

  2004cited by this paper
• Targeted Disruption of the Microsomal Epoxide Hydrolase Gene

  1999cited by this paper
• Assembly of the Warfarin-sensitive Vitamin K 2,3-Epoxide Reductase Enzyme Complex in the Endoplasmic Reticulum Membrane*

  1997cited by this paper
• Vitamin K and energy transduction: a base strength amplification mechanism.

  1995cited by this paper
• Short-chain phosphatidylcholines as superior detergents in solubilizing membrane proteins and preserving biological activity.

  1994cited by this paper
• Identification and purification to near homogeneity of the vitamin K-dependent carboxylase.

  1991cited by this paper
• Reduced thioredoxin: a possible physiological cofactor for vitamin K epoxide reductase. Further support for an active site disulfide.

  1988cited by this paper
• The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibody.

  1988cited by this paper
• Vitamin K 2,3‐epoxide reductase: the basis for stereoselectivity of 4‐hydroxycoumarin anticoagulant activity

  1988cited by this paper
• Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.

  1985cited by this paper
• Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.

  1985cited by this paper
• Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition.

  1978cited by this paper
• Changes in phylloquinone epoxidase activity related to prothrombin synthesis and microsomal clotting activity in the rat.

  1974cited by this paper
• Warfarin and the Inhibition of Vitamin K Activity by an Oxide Metabolite

  1972cited by this paper

• Clinical, Laboratory, and Molecular Characteristics of Inherited Vitamin K–Dependent Coagulation Factors Deficiency

  2024cites this paper
• Identification of complex III, NQR, and SDH as primary bioenergetic enzymes during the stationary phase of Pseudomonas aeruginosa cultured in urine-like conditions

  2024cites this paper
• Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism.

  2023cites this paper
• Diverse biological functions of vitamin K: from coagulation to ferroptosis

  2023cites this paper
• A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase

  2023cites this paper
• Distinct enzymatic strategies for de novo generation of disulfide bonds in membranes

  2023cites this paper
• Missense VKOR mutants exhibit severe warfarin resistance but lack VKCFD via shifting to an aberrantly reduced state

  2022cites this paper
• Clinical pharmacogenetics

  2022cites this paper
• Structural features determining the vitamin K epoxide reduction activity in the VKOR family of membrane oxidoreductases

  2022cites this paper
• Structural and cellular basis of vitamin K antagonism

  2022cites this paper
• Targeting multiple enzymes in vitamin K metabolism for anticoagulation

  2021cites this paper
• Vitamin K2 promotes the osteogenic differentiation of periodontal ligament stem cells via the Wnt/β-catenin signaling pathway.

  2021cites this paper
• Preparation of Vitamin K2 Mk-7 in a Process of Fermentation of Different Seeds and Cereals by Bacteria Bacillus Subtilis

  2021cites this paper
• Characterization of Warfarin Inhibition Kinetics Requires Stabilization of Intramembrane Vitamin K Epoxide Reductases.

  2020cites this paper
• Termini restraining of small membrane proteins enables structure determination at near-atomic resolution

  2020cites this paper
• Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation

  2020cites this paper
• Competitive tight-binding inhibition of VKORC1 underlies warfarin dosage variation and antidotal efficacy.

  2020cites this paper
• The aerobic respiratory chain of Pseudomonas aeruginosa cultured in artificial urine media: Role of NQR and terminal oxidases

  2020cites this paper
• New Aspects of Vitamin K Research with Synthetic Ligands: Transcriptional Activity via SXR and Neural Differentiation Activity

  2019cites this paper
• Superwarfarin (Long-Acting Anticoagulant Rodenticides) Poisoning: from Pathophysiology to Laboratory-Guided Clinical Management.

  2019cites this paper
• VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.

  2018cites this paper
• Structural and Functional Basis of Difructose Anhydride III Hydrolase, Which Sequentially Converts Inulin Using the Same Catalytic Residue

  2018cites this paper
• VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues

  2018cites this paper
• Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism.

  2017cites this paper
• Phylloquinone (Vitamin K1): Occurrence, Biosynthesis and Functions.

  2017cites this paper
• Membrane Protein Structure in Live Cells: Methodology for Studying Drug Interaction by Mass Spectrometry-Based Footprinting.

  2017cites this paper
• Intramembrane Thiol Oxidoreductases: Evolutionary Convergence and Structural Controversy.

  2017cites this paper
• Functional Study of the Vitamin K Cycle Enzymes in Live Cells.

  2017cites this paper
• Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer

  2016cites this paper
• Structural and functional insights into enzymes of the vitamin K cycle

  2016cites this paper
• Stabilization and detection of hydrophylloquinone as di-O-methyl derivative.

  2016cites this paper
• Comparative Biology of the Resistance to Vitamin K Antagonists: An Overview of the Resistance Mechanisms

  2016cites this paper
• Development of neuro-fuzzy model to explore gene-nutrient interactions modulating warfarin dose requirement.

  2016cites this paper
• Warfarin and vitamin K compete for binding to Phe55 in human VKOR

  2016cites this paper
• Étude de l'impact du sexe sur la coagulation vitamine K dépendante chez le rat

  2016cites this paper
• Membrane composition influences the activity of in vitro refolded human vitamin K epoxide reductase.

  2015cites this paper
• VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?

  2015cites this paper
• GGCX and VKORC1 inhibit osteocalcin endocrine functions

  2015cites this paper
• Tris(3-hydroxypropyl)phosphine is superior to dithiothreitol for in vitro assessment of vitamin K 2,3-epoxide reductase activity.

  2015cites this paper
• L'accélération de la rigidité vasculaire associée au diabète de type 1 : implication de la protéine Gla de la matrice

  2015cites this paper
• Altered Escherichia coli membrane protein assembly machinery allows proper membrane assembly of eukaryotic protein vitamin K epoxide reductase

  2015cites this paper
• Die Arterialisation der Shuntvene unter Berücksichtigung des Vitamin K Stoffwechsels und der Urämie

  2015cites this paper
• Tris(3-hydroxypropyl)phosphine (THPP): A mild, air-stable reagent for the rapid, reductive cleavage of small-molecule disulfides.

  2015cites this paper
• Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis

  2014cites this paper
• Conserved Loop Cysteines of Vitamin K Epoxide Reductase Complex Subunit 1-like 1 (VKORC1L1) Are Involved in Its Active Site Regeneration*

  2014cites this paper
• Study Of Genetic And Pharmacokinetic Issues Related To Efficacy And Toxicity Of Warfarin In Pakistani Subjects

  2014cites this paper
• Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation.

  2014cites this paper
• Membrane protein structures for rational antimicrobial drug design

  2014cites this paper
• Intra-molecular electron transfer in VKORC 1 L 1 1 Conserved Loop Cysteines of Vitamin K Epoxide Reductase Complex Subunit 1-Like 1 ( VKORC 1 L 1 ) Are Involved in Its Active Site Regeneration *

  2014cites this paper
• A new cell culture‐based assay quantifies vitamin K 2,3‐epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol‐driven VKOR assay

  2013cites this paper
• Decreased expression of γ-carboxylase in diabetes-associated arterial stiffness: impact on matrix Gla protein.

  2013cites this paper
• Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1

  2013influential citation
• Assessment of the contribution of NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) to the reduction of vitamin K in wild-type and NQO1-deficient mice.

  2013cites this paper
• Evaluation of warfarin resistance using transcription activator‐like effector nucleases‐mediated vitamin K epoxide reductase knockout HEK293 cells

  2013cites this paper
• The Vitamin K Oxidoreductase Is a Multimer That Efficiently Reduces Vitamin K Epoxide to Hydroquinone to Allow Vitamin K-dependent Protein Carboxylation*

  2013influential citation
• Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1

  2013cites this paper
• VKORC1L1, an Enzyme Rescuing the Vitamin K 2,3-Epoxide Reductase Activity in Some Extrahepatic Tissues during Anticoagulation Therapy*

  2013cites this paper
• Anticoagulation Therapy in Some Extrahepatic Tissues during Vitamin K 2 , 3-Epoxide Reductase Activity VKORC 1 L 1 , an Enzyme Rescuing the Enzymology :

  2013cites this paper
• Evaluation of warfarin resistance using TALENs-mediated vitamin K epoxide reductase knockout HEK293 cells

  2013cites this paper
• Chapter 7 – Evaluation of Hemostasis: Coagulation and Platelet Disorders

  2012cites this paper
• A fluorescent method to determine vitamin K-dependent gamma-glutamyl carboxylase activity.

  2012influential citation
• Biochemical and Mechanistic Studies of the Interactions Between Vitamin K Antagonists and Vitamin K Epoxide Reductase

  2012influential citation
• Glutamate: a truly functional amino acid

  2012cites this paper
• Les populations invasives de rongeurs en milieu agricole : une étude menée dans des cultures de grande échelle, les plantations de palmiers à huile en Indonésie : Approche paysagère, génétique et écotoxicologique

  2012cites this paper
• Vitamin K1 (Phylloquinone): Function, Enzymes and Genes

  2011cites this paper
• Biochemical characterization of spontaneous mutants of rat VKORC1 involved in the resistance to antivitamin K anticoagulants.

  2011cites this paper
• Apolipoprotein E Genotype Association with Time to Stable Warfarin Dosing in African Americans

  2011cites this paper
• Proteomics and metabolomics analysis of cellular response to anti-coagulating drug warfarin.

  2011cites this paper
• Human Vitamin K 2,3-Epoxide Reductase Complex Subunit 1-like 1 (VKORC1L1) Mediates Vitamin K-dependent Intracellular Antioxidant Function*

  2011cites this paper
• Clinical applicability of sequence variations in genes related to drug metabolism.

  2011cites this paper
• More on: endoplasmic reticulum loop VKORC1 substitutions cause warfarin resistance but do not diminish gamma‐carboxylation of the vitamin K‐dependent coagulation factors

  2011cites this paper
• Remarkable features of the hotdog-fold thioesterases involved in phylloquinone (vitamin K1) biosynthesis

  2011cites this paper
• Functional study of the vitamin K cycle in mammalian cells.

  2011cites this paper
• Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment

  2011cites this paper
• Exon sequencing and association analysis of EPHX1 genetic variants with maintenance warfarin dose in a multiethnic Asian population

  2011cites this paper
• Association of Apolipoprotein E Genotype with Duration of Time to Achieve a Stable Warfarin Dose in African‐American Patients

  2011cites this paper
• A bimodular oxidoreductase mediates the specific reduction of phylloquinone (vitamin K₁) in chloroplasts.

  2010cites this paper
• Distribution of VKORC1 single nucleotide polymorphism in wild Rattus norvegicus in France.

  2010cites this paper
• Anticoagulant resistance in Norway rats (Rattus norvegicus Berk.) in Kent – a VKORC1 single nucleotide polymorphism, tyrosine139phenylalanine, new to the UK

  2010cites this paper
• A comparative proteomic analysis of HepG2 cells incubated by S(−) and R(+) enantiomers of anti‐coagulating drug warfarin

  2010cites this paper
• Identification of VKORC1 interaction partners by split-ubiquitin system and coimmunoprecipitation

  2010cites this paper
• Structure of a bacterial homolog of vitamin K epoxide reductase

  2010cites this paper
• Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2.

  2009cites this paper
• Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms.

  2009cites this paper
• Vitamin K–Dependent Coagulation Factors Deficiency

  2009cites this paper
• Vitamin K-Dependent Carboxylase and Vitamin K Epoxide Reductase

  2009cites this paper
• Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin

  2009cites this paper
• VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.

  2008cites this paper
• Structure and function of vitamin K epoxide reductase.

  2008cites this paper
• Detection and quantification of vitamin K(1) quinol in leaf tissues.

  2008cites this paper
• Warfarin resistance in Rattus losea in Guangdong Province, China

  2008cites this paper
• Vitamin K-dependent gamma-glutamylcarboxylation: an ancient posttranslational modification.

  2008cites this paper
• The vitamin K cycle.

  2008cites this paper
• Identification of an Atypical Membrane Protein Involved in the Formation of Protein Disulfide Bonds in Oxygenic Photosynthetic Organisms*

  2008cites this paper
• Vitamin K and rheumatoid arthritis

  2008cites this paper
• Vitamin K Cycles and γ-Carboxylation of Coagulation Factors

  2008cites this paper
• No association between vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) and the variability of warfarin dose requirement in a Japanese patient population.

  2008cites this paper
• Stable isotope studies into the kinetics and bioavailability of vitamin K₁ in humans

  2007cites this paper
• Vitamin K: The coagulation vitamin that became omnipotent

  2007cites this paper
• Factors influencing warfarin dose requirements in African-Americans.

  2007cites this paper